Neurosurgical Devices – Market Insights – Europe

While the European neurosurgical device market will be significantly limited by competing treatments, growth will be maintained by continued adoption of premium-priced devices and the advancement of technology within the majority of neurosurgical markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurosurgical devices in the US across a 10-year period.

Innovative technology coming to Europe provides opportunity for companies to acquire and enter new markets

What neurosurgical markets are currently under saturated in Europe?

Where is there the most opportunity for growth within the European neurosurgical market?

Which companies are leading the way with innovative technology in Europe?

Continued technological advancements drive replacement sales and increases in ASPs

Which markets are seeing the largest research and development efforts?

How are health care facilities balancing cost effectiveness with the increased efficacy of new higher priced devices?

Which higher priced devices are seeing increased procedure volumes and how is this impacting the overall market?

Neurosurgeons are reluctant to adopt new medical devices.

What factors will drive adoption of more recently launched novel neurosurgery devices?

How does this reluctance affect adoption of premium-priced next-generation devices?

Table of contents

Neurosurgical Devices - Market Insights - Europe

Ashish Bhupal, MBA

Ashish Bhupal is a senior manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor’s in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution.

Follow Ashish on Twitter: @Ashishb_DRG.

Contact sales Login to access report

Back to all Medtech Insights reports